Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis
about
Antigen-based immunotherapy for autoimmune disease: current statusRestoring immune tolerance in neuromyelitis optica: Part IThe role of antigen presenting cells in multiple sclerosis.Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in MiceMechanisms of immunological tolerance in central nervous system inflammatory demyelination.Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosisEngineering antigens for in situ erythrocyte binding induces T-cell deletion.Emerging immunopharmacological targets in multiple sclerosis.Immunomodulation of RA Patients' PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens.The inside story of dendritic cell immunotherapy.Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog.Immune Modulation and Prevention of Autoimmune Disease by Repeated Sequences from Parasites Linked to Self Antigens.Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis.Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
P2860
Q26852915-88516D42-367B-47D8-89A8-7DA08759AB2AQ28072382-D29D9EE2-8A73-45CD-8F13-502D2D55AEDBQ34268029-A8B64CE1-6507-4178-875F-7318B1D82B18Q35894465-4E7D5AB6-2573-448B-9B0A-451F0DFEEBBFQ36095922-C444229B-CF28-4A9C-892E-A3D9C31A74A3Q36174813-06C18A42-D936-49E9-BCE7-A3D0AC790D7BQ36512070-D6BB6784-9869-4151-A3EC-0F654FC7B581Q37559970-C493422A-F81E-4656-A6D1-7CBDEDDC6A0EQ40961898-1A18A646-C343-4A37-81EF-AD88FB8CC5BCQ42431627-50B5E332-A6BB-4AE8-AD65-AC35971F8572Q46438033-E497518E-2022-42E6-80BB-FC535C062A34Q51574850-D4ABD3AD-36BA-43A2-8624-5F3F328117F2Q54211751-5159CB81-281B-4A77-8CE5-3972DBADD146Q55258910-3EDD4DB4-5400-461C-AA65-F754CD24144B
P2860
Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospects for antigen-specific ...... reatment of multiple sclerosis
@en
Prospects for antigen-specific ...... eatment of multiple sclerosis.
@nl
type
label
Prospects for antigen-specific ...... reatment of multiple sclerosis
@en
Prospects for antigen-specific ...... eatment of multiple sclerosis.
@nl
prefLabel
Prospects for antigen-specific ...... reatment of multiple sclerosis
@en
Prospects for antigen-specific ...... eatment of multiple sclerosis.
@nl
P2860
P356
P1476
Prospects for antigen-specific ...... reatment of multiple sclerosis
@en
P2093
Danielle M Turley
Stephen D Miller
P2860
P304
P356
10.1007/400_2008_13
P577
2010-01-01T00:00:00Z